These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 25266004

  • 1. Improved immunogenicity of tetanus toxoid by Brucella abortus S19 LPS adjuvant.
    Mohammadi M, Kianmehr Z, Kaboudanian Ardestani S, Gharegozlou B.
    Iran J Immunol; 2014 Sep; 11(3):189-99. PubMed ID: 25266004
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J.
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Influence of Brucella abortus lipopolysaccharide as an adjuvant on the immunogenicity of HPV-16 L1VLP vaccine in mice.
    Kianmehr Z, Soleimanjahi H, Ardestani SK, Fotouhi F, Abdoli A.
    Med Microbiol Immunol; 2015 Apr; 204(2):205-13. PubMed ID: 25187406
    [Abstract] [Full Text] [Related]

  • 6. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ, Manterola L, de Miguel MJ, Muñoz PM, Blasco JM, Moriyón I, López-Goñi I.
    Vaccine; 2006 Apr 05; 24(15):2910-6. PubMed ID: 16439039
    [Abstract] [Full Text] [Related]

  • 7. The effects of adjuvants on immune responses in cattle injected with a Brucella abortus soluble antigen.
    Dzata GK, Confer AW, Wyckoff JH.
    Vet Microbiol; 1991 Sep 05; 29(1):27-48. PubMed ID: 1835213
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid.
    Gupta RK, Siber GR.
    Biologicals; 1994 Mar 05; 22(1):53-63. PubMed ID: 8068314
    [Abstract] [Full Text] [Related]

  • 11. Novel influenza virus vectors expressing Brucella L7/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection.
    Tabynov K, Kydyrbayev Z, Ryskeldinova S, Yespembetov B, Zinina N, Assanzhanova N, Kozhamkulov Y, Inkarbekov D, Gotskina T, Sansyzbay A.
    Vaccine; 2014 Apr 11; 32(18):2034-41. PubMed ID: 24598723
    [Abstract] [Full Text] [Related]

  • 12. Antibody response against tetanus toxoid is enhanced by lipopolysaccharide or tumor necrosis factor-alpha in vitamin A-sufficient and deficient rats.
    Arora D, Ross AC.
    Am J Clin Nutr; 1994 Apr 11; 59(4):922-8. PubMed ID: 8147339
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Adjuvant properties of lipopolysaccharide from Neisseria meningitidis serogroup B detoxified and conjugated with tetanus toxoid.
    Balboa JA, Cuello M, Cabrera O, del Campo J, Lastre M, Gil D, Taboada C, Fariñas M, Hernández M, Pérez O.
    Vaccine; 2006 Apr 12; 24 Suppl 2():S2-63-4. PubMed ID: 16823931
    [Abstract] [Full Text] [Related]

  • 15. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godefroid J, Walravens K, Letesson JJ.
    Infect Immun; 2001 Aug 12; 69(8):4816-22. PubMed ID: 11447155
    [Abstract] [Full Text] [Related]

  • 16. Recombinant bovine interleukin 2 enhances immunity and protection induced by Brucella abortus vaccines in cattle.
    Wyckoff JH, Howland JL, Scott CM, Smith RA, Confer AW.
    Vet Microbiol; 2005 Nov 30; 111(1-2):77-87. PubMed ID: 16242273
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of Biological and Immunological Characterization of Lipopolysaccharides From Brucella abortus RB51 and S19.
    Kianmehr Z, Kaboudanian Ardestani S, Soleimanjahi H, Fotouhi F, Alamian S, Ahmadian S.
    Jundishapur J Microbiol; 2015 Nov 30; 8(11):e24853. PubMed ID: 26862376
    [Abstract] [Full Text] [Related]

  • 19. Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice.
    Adone R, Francia M, Pistoia C, Petrucci P, Pesciaroli M, Pasquali P.
    Vaccine; 2012 Jun 08; 30(27):3992-5. PubMed ID: 22521283
    [Abstract] [Full Text] [Related]

  • 20. Conjugation of tetanus toxoid with Salmonella typhimurium PTCC 1735 O-specific polysaccharide and its effects on production of opsonizing antibodies in a mouse model.
    Jazani NH, Worobec E, Shahabi S, Nejad GB.
    Can J Microbiol; 2005 Apr 08; 51(4):319-24. PubMed ID: 15980894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.